<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="several health-related implications, such as pain, cold, urinary tract disorders," exact="rheumatoid arthritis," post="gastric ulcer, abdominal pain, cholera, and beriberi [3,4]. Surprisingly,"/>
 <result pre="implications, such as pain, cold, urinary tract disorders, rheumatoid arthritis," exact="gastric ulcer," post="abdominal pain, cholera, and beriberi [3,4]. Surprisingly, plants of"/>
 <result pre="tract disorders, rheumatoid arthritis, gastric ulcer, abdominal pain, cholera, and" exact="beriberi" post="[3,4]. Surprisingly, plants of the Lindera genus have been"/>
 <result pre="chronic obstructive pulmonary, and chronic kidney diseases as well as" exact="cancer" post="[10]. Reactive oxygen participates in the high-energy electron transfer"/>
 <result pre="used as traditional medicines for their therapeutic effect on whitening," exact="hepatitis" post="C, hepatotoxicity, anti-cancer, antibacterial, antiproliferative, endothelial dysfunction, neuroprotection, antifibrotic,"/>
 <result pre="down-regulating the NF-ÎºB signalling pathway [33]. In addition, lucidone suppressed" exact="hepatitis" post="C viral replication by induction of Nrf-2-Mediated HO-1 in"/>
 <result pre="to attenuate oxidative stress and airway inflammation in ovalbumin-challenged (OVA)" exact="asthma" post="mice and TNF-Î±-stimulated NCI-H292 cells (Figure 2). In TNF-Î±-stimulated"/>
 <result pre="LOLE in both in vivo and in vitro analyses of" exact="allergic asthma" post="[15]. In another study of ovalbumin (OVA)-challenged mice, treatment"/>
 <result pre="in both in vivo and in vitro analyses of allergic" exact="asthma" post="[15]. In another study of ovalbumin (OVA)-challenged mice, treatment"/>
 <result pre="significant cytotoxicity against five different human cell lines: no-small cell" exact="lung cancer" post="(A549), skin cancer (SK-MEL-2), CNS cancer (XF498), ovarian (SK-OV-3)"/>
 <result pre="cytotoxicity against five different human cell lines: no-small cell lung" exact="cancer" post="(A549), skin cancer (SK-MEL-2), CNS cancer (XF498), ovarian (SK-OV-3)"/>
 <result pre="five different human cell lines: no-small cell lung cancer (A549)," exact="skin cancer" post="(SK-MEL-2), CNS cancer (XF498), ovarian (SK-OV-3) and colon cancer"/>
 <result pre="different human cell lines: no-small cell lung cancer (A549), skin" exact="cancer" post="(SK-MEL-2), CNS cancer (XF498), ovarian (SK-OV-3) and colon cancer"/>
 <result pre="lines: no-small cell lung cancer (A549), skin cancer (SK-MEL-2), CNS" exact="cancer" post="(XF498), ovarian (SK-OV-3) and colon cancer (HCT15) [63]. 5.4."/>
 <result pre="(A549), skin cancer (SK-MEL-2), CNS cancer (XF498), ovarian (SK-OV-3) and" exact="colon cancer" post="(HCT15) [63]. 5.4. Hepatoprotective Activity In an in vitro"/>
 <result pre="skin cancer (SK-MEL-2), CNS cancer (XF498), ovarian (SK-OV-3) and colon" exact="cancer" post="(HCT15) [63]. 5.4. Hepatoprotective Activity In an in vitro"/>
 <result pre="vascular smooth muscle cells (VSMC) is a major contributor to" exact="atherosclerosis" post="and generates ROS. Increased ROS promotes acute inflammatory responses"/>
 <result pre="proven to be a rational approach in the treatment of" exact="atherosclerosis" post="[74]. The lignan (+)-episesamin, one of the active constituents"/>
 <result pre="kinase; TH, tyrosine hydroxylase; LDH, lactose dehydrogenase; MTT, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide;" exact="hepatocellular carcinoma" post="cells; ERK, extracellular receptor kinase; AKT, reduced protein kinase"/>
 <result pre="and down-regulation of NF-ÎºB signaling pathwayFood Chem. Toxicol.201359556610.1016/j.fct.2013.04.05523712098 34.ChenW.C.WangS.Y.ChiuC.C.TsengC.K.LinC.K.WangH.C.LeeJ.C.Lucidone suppresses" exact="hepatitis" post="C virus replication by Nrf2-mediated heme oxygenase-1 inductionAntimicrob. Agents"/>
 <result pre="like growth factor-1 receptor signaling and NF-kappaB activity in human" exact="liver cancer" post="cell linesBmc Complementary Altern. Med.2011113910.1186/1472-6882-11-39 58.FacciolaS.Cornucopia: A Source Book"/>
 <result pre="growth factor-1 receptor signaling and NF-kappaB activity in human liver" exact="cancer" post="cell linesBmc Complementary Altern. Med.2011113910.1186/1472-6882-11-39 58.FacciolaS.Cornucopia: A Source Book"/>
 <result pre="Soc. Jpn.198357663666 65.BajpaiV.K.AlamM.B.QuanK.T.JuM.K.MajumderR.ShuklaS.HanY.K.Attenuation of inflammatory responses by (+)-syringaresinol via MAP-Kinase-mediated" exact="suppression" post="of NF-ÎºB signaling in vitro and in vivoSci. Rep.2018811010.1038/s41598-018-27585-w29311619"/>
 <result pre="BlumeArch. Pharmacal Res.19992241742210.1007/BF0297906910489885 68.ParkB.Y.OhS.R.AhnK.S.KwonO.K.LeeH.K.(â€&quot;)-Syringaresinol inhibits proliferation of human promyelocytic HL-60" exact="leukemia" post="cells via G1 arrest and apoptosisInt. Immunopharmacol.2008896797310.1016/j.intimp.2008.02.01218486907 69.Trowitzsch-KienastW.RÃ¼hlM.KimK.Y.EmmerlingF.ErbenU.SomasundaramR.FreiseC.Absolute Configuration"/>
 <result pre="Lindera obtusiloba induce antifibrotic effects in hepatic stellate cells via" exact="suppression" post="of a TGF-Î²-mediated profibrotic gene expression patternJ. Nutr. Biochem.20092059760610.1016/j.jnutbio.2008.06.00318824344"/>
 <result pre="expression [15] L. obtusiloba EtOH stem In vivo: type 2" exact="diabetes mellitus" post="mice model 100 mg/kg - expression of the NADPH"/>
</results>
